Cockayne syndrome mutation in XPG activate the integrated stress response

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are genetic disorders caused by mutations in DNA repair proteins.
• XP is characterized by high cancer incidence due to DNA repair deficiency.
• CS presents with growth retardation, neurological degeneration, and premature aging, without classical DNA repair deficiency.

Purpose of the Study:

• To differentiate the cellular disturbances causing CS from XP.
• To investigate the molecular mechanisms underlying CS pathogenesis.
• To compare a combined XP/CS case with an XP-only case, both involving XPG mutations.

Main Methods:

• Comparative analysis of a severe combined XP/CS patient case (XPG mutation) and an XP-only patient cell line (XPG mutation).
• Assessment of RNA polymerase I transcription and rRNA maturation.
• Evaluation of eukaryotic initiation factor 2 alpha (eIF2alpha) phosphorylation and translation initiation mechanisms (cap-dependent vs. IRES).

Main Results:

• Identified defects in RNA polymerase I transcription and rRNA maturation in the CS case.
• Observed a highly phosphorylated eIF2alpha, indicative of an integrated stress response.
• Detected a shift in translation from cap-dependent to internal ribosomal entry site (IRES) initiation in CS.

Conclusions:

• The integrated stress response and altered translational control are key features of CS, distinguishing it from XP.
• Disturbances in ribosomal biogenesis and translational regulation may contribute to CS development.
• Understanding these distinct cellular defects is crucial for differentiating XP and CS and for future therapeutic strategies.